What are the most effective pharmacologic treatments for adults with chronic primary insomnia?
Vanessa Rivera, Ruben Salinas
Abstract
Vanessa Rivera, Ruben Salinas
Abstract
EVIDENCE-BASED ANSWER Benzodiazepines (particularly triazolam for 1 week) and nonbenzodiazepine hypnotic agents (particularly zolpidem and zopiclone for 2–5 weeks) modestly improve sleep-onset latency and subjective sleep reporting (SOR: B, meta-analysis of RCTs with publication bias and heterogeneity). Ramelteon does not improve sleep-onset latency or subjective sleep reporting to a clinically significant extent (SOR: B, meta-analysis of low quality RCTs).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
EVIDENCE-BASED ANSWER Benzodiazepines (particularly triazolam for 1 week) and nonbenzodiazepine hypnotic agents (particularly zolpidem and zopiclone for 2–5 weeks) modestly improve sleep-onset latency and subjective sleep reporting (SOR: B, meta-analysis of RCTs with publication bias and heterogeneity). Ramelteon does not improve sleep-onset latency or subjective sleep reporting to a clinically significant extent (SOR: B, meta-analysis of low quality RCTs).
Key concepts: Zolpidem, Zopiclone, Sleep onset latency, Triazolam, Insomnia, Primary Insomnia, Hypnotic, Medicine